Paruzzo, Luca
Paruzzo, Luca
ONCOLOGIA
CD5 deletion enhances the antitumor activity of adoptive T cell therapies
2024-01-01 Patel, Ruchi P; Ghilardi, Guido; Zhang, Yunlin; Chiang, Yi-Hao; Xie, Wei; Guruprasad, Puneeth; Kim, Ki Hyun; Chun, Inkook; Angelos, Mathew G; Pajarillo, Raymone; Hong, Seok Jae; Lee, Yong Gu; Shestova, Olga; Shaw, Carolyn; Cohen, Ivan; Gupta, Aasha; Vu, Trang; Qian, Dean; Yang, Steven; Nimmagadda, Aditya; Snook, Adam E; Siciliano, Nicholas; Rotolo, Antonia; Inamdar, Arati; Harris, Jaryse; Ugwuanyi, Ositadimma; Wang, Michael; Carturan, Alberto; Paruzzo, Luca; Chen, Linhui; Ballard, Hatcher J; Blanchard, Tatiana; Xu, Chong; Abdel-Mohsen, Mohamed; Gabunia, Khatuna; Wysocka, Maria; Linette, Gerald P; Carreno, Beatriz; Barrett, David M; Teachey, David T; Posey, Avery D; Powell, Daniel J; Sauter, C Tor; Pileri, Stefano; Pillai, Vinodh; Scholler, John; Rook, Alain H; Schuster, Stephen J; Barta, Stefan K; Porazzi, Patrizia; Ruella, Marco
CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma
2023-01-01 Giraudo, Lidia; Cattaneo, Giulia; Gammaitoni, Loretta; Iaia, Ilenia; Donini, Chiara; Massa, Annamaria; Centomo, Maria Laura; Basiricò, Marco; Vigna, Elisa; Pisacane, Alberto; Picciotto, Franco; Berrino, Enrico; Marchiò, Caterina; Merlini, Alessandra; Paruzzo, Luca; Poletto, Stefano; Caravelli, Daniela; Biolato, Andrea Michela; Bortolot, Valentina; Landoni, Elisa; Ventin, Marco; Ferrone, Cristina R; Aglietta, Massimo; Dotti, Gianpietro; Leuci, Valeria; Carnevale-Schianca, Fabrizio; Sangiolo, Dario
Current Controversies and Challenges on BRAF V600K-Mutant Cutaneous Melanoma
2022-01-01 Nepote A.; Avallone G.; Ribero S.; Cavallo F.; Roccuzzo G.; Mastorino L.; Conforti C.; Paruzzo L.; Poletto S.; Schianca F.C.; Quaglino P.; Aglietta M.
High BRAF variant allele frequencies are associated with distinct pathological features and responsiveness to target therapy in melanoma patients
2021-01-01 Berrino E.; Balsamo A.; Pisacane A.; Gallo S.; Becco P.; Miglio U.; Caravelli D.; Poletto S.; Paruzzo L.; Debernardi C.; Piccinelli C.; Zaccagna A.; Rescigno P.; Aglietta M.; Sapino A.; Carnevale-Schianca F.; Venesio T.
HSCT with Mismatched Unrelated Donors (MMUD): A Comparison of Different Platforms for GvHD Prophylaxis
2022-01-01 Berger M; Barone M; Carnevale-Schianca F; De Gobbi M; Nicoli P; Caravelli D ; Cilloni D ; Paruzzo L ; Spadea M ; Mareschi K ; Aglietta M; Fagioli F
Melanoma Brain Metastases in the Era of Target Therapies: An Overview
2020-01-01 Becco, Paolo; Gallo, Susanna; Poletto, Stefano; Frascione, Mirko Pio Manlio; Crotto, Luca; Zaccagna, Alessandro; Paruzzo, Luca; Caravelli, Daniela; Carnevale-Schianca, Fabrizio; Aglietta, Massimo
Post-Transplant Cyclophosphamide and Tacrolimus-Mycophenolate Mofetil Combination Governs GVHD and Immunosuppression Need, Reducing Late Toxicities in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors
2021-01-01 Carnevale-Schianca, Fabrizio; Caravelli, Daniela; Gallo, Susanna; Becco, Paolo; Paruzzo, Luca; Poletto, Stefano; Polo, Alessandra; Mangioni, Monica; Salierno, Milena; Berger, Massimo; Pessolano, Rosanna; Saglio, Francesco; Gottardi, Daniela; Rota-Scalabrini, Delia; Grignani, Giovanni; Fizzotti, Marco; Ferrero, Ivana; Frascione, Pio Manlio Mirko; D'Ambrosio, Lorenzo; Gaidano, Valentina; Gammaitoni, Loretta; Sangiolo, Dario; Saglietto, Andrea; Vassallo, Elena; Cignetti, Alessandro; Aglietta, Massimo; Fagioli, Franca
Predictive Factors in Metastatic Melanoma Treated with Immune Checkpoint Inhibitors: From Clinical Practice to Future Perspective
2023-01-01 Poletto, Stefano; Paruzzo, Luca; Nepote, Alessandro; Caravelli, Daniela; Sangiolo, Dario; Carnevale-Schianca, Fabrizio
Treatment strategies for patients with diffuse large B-cell lymphoma
2022-01-01 Poletto, Stefano; Novo, Mattia; Paruzzo, Luca; Frascione, Pio Manlio Mirko; Vitolo, Umberto
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| CD5 deletion enhances the antitumor activity of adoptive T cell therapies | 2024 | Patel, Ruchi P; Ghilardi, Guido; Zhang, Yunlin; Chiang, Yi-Hao; Xie, Wei; Guruprasad, Puneeth; Kim, Ki Hyun; Chun, Inkook; Angelos, Mathew G; Pajarillo, Raymone; Hong, Seok Jae; Lee, Yong Gu; Shestova, Olga; Shaw, Carolyn; Cohen, Ivan; Gupta, Aasha; Vu, Trang; Qian, Dean; Yang, Steven; Nimmagadda, Aditya; Snook, Adam E; Siciliano, Nicholas; Rotolo, Antonia; Inamdar, Arati; Harris, Jaryse; Ugwuanyi, Ositadimma; Wang, Michael; Carturan, Alberto; Paruzzo, Luca; Chen, Linhui; Ballard, Hatcher J; Blanchard, Tatiana; Xu, Chong; Abdel-Mohsen, Mohamed; Gabunia, Khatuna; Wysocka, Maria; Linette, Gerald P; Carreno, Beatriz; Barrett, David M; Teachey, David T; Posey, Avery D; Powell, Daniel J; Sauter, C Tor; Pileri, Stefano; Pillai, Vinodh; Scholler, John; Rook, Alain H; Schuster, Stephen J; Barta, Stefan K; Porazzi, Patrizia; Ruella, Marco | |
| CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma | 2023 | Giraudo, Lidia; Cattaneo, Giulia; Gammaitoni, Loretta; Iaia, Ilenia; Donini, Chiara; Massa, Annamaria; Centomo, Maria Laura; Basiricò, Marco; Vigna, Elisa; Pisacane, Alberto; Picciotto, Franco; Berrino, Enrico; Marchiò, Caterina; Merlini, Alessandra; Paruzzo, Luca; Poletto, Stefano; Caravelli, Daniela; Biolato, Andrea Michela; Bortolot, Valentina; Landoni, Elisa; Ventin, Marco; Ferrone, Cristina R; Aglietta, Massimo; Dotti, Gianpietro; Leuci, Valeria; Carnevale-Schianca, Fabrizio; Sangiolo, Dario | |
| Current Controversies and Challenges on BRAF V600K-Mutant Cutaneous Melanoma | 2022 | Nepote A.; Avallone G.; Ribero S.; Cavallo F.; Roccuzzo G.; Mastorino L.; Conforti C.; Paruzzo L.; Poletto S.; Schianca F.C.; Quaglino P.; Aglietta M. | |
| High BRAF variant allele frequencies are associated with distinct pathological features and responsiveness to target therapy in melanoma patients | 2021 | Berrino E.; Balsamo A.; Pisacane A.; Gallo S.; Becco P.; Miglio U.; Caravelli D.; Poletto S.; Paruzzo L.; Debernardi C.; Piccinelli C.; Zaccagna A.; Rescigno P.; Aglietta M.; Sapino A.; Carnevale-Schianca F.; Venesio T. | |
| HSCT with Mismatched Unrelated Donors (MMUD): A Comparison of Different Platforms for GvHD Prophylaxis | 2022 | Berger M; Barone M; Carnevale-Schianca F; De Gobbi M; Nicoli P; Caravelli D ; Cilloni D ; Paruzzo L ; Spadea M ; Mareschi K ; Aglietta M; Fagioli F | |
| Melanoma Brain Metastases in the Era of Target Therapies: An Overview | 2020 | Becco, Paolo; Gallo, Susanna; Poletto, Stefano; Frascione, Mirko Pio Manlio; Crotto, Luca; Zaccagna, Alessandro; Paruzzo, Luca; Caravelli, Daniela; Carnevale-Schianca, Fabrizio; Aglietta, Massimo | |
| Post-Transplant Cyclophosphamide and Tacrolimus-Mycophenolate Mofetil Combination Governs GVHD and Immunosuppression Need, Reducing Late Toxicities in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors | 2021 | Carnevale-Schianca, Fabrizio; Caravelli, Daniela; Gallo, Susanna; Becco, Paolo; Paruzzo, Luca; Poletto, Stefano; Polo, Alessandra; Mangioni, Monica; Salierno, Milena; Berger, Massimo; Pessolano, Rosanna; Saglio, Francesco; Gottardi, Daniela; Rota-Scalabrini, Delia; Grignani, Giovanni; Fizzotti, Marco; Ferrero, Ivana; Frascione, Pio Manlio Mirko; D'Ambrosio, Lorenzo; Gaidano, Valentina; Gammaitoni, Loretta; Sangiolo, Dario; Saglietto, Andrea; Vassallo, Elena; Cignetti, Alessandro; Aglietta, Massimo; Fagioli, Franca | |
| Predictive Factors in Metastatic Melanoma Treated with Immune Checkpoint Inhibitors: From Clinical Practice to Future Perspective | 2023 | Poletto, Stefano; Paruzzo, Luca; Nepote, Alessandro; Caravelli, Daniela; Sangiolo, Dario; Carnevale-Schianca, Fabrizio | |
| Treatment strategies for patients with diffuse large B-cell lymphoma | 2022 | Poletto, Stefano; Novo, Mattia; Paruzzo, Luca; Frascione, Pio Manlio Mirko; Vitolo, Umberto |